M. H. Jeong

Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.

Min Chul Kim, D. Sim, Dong-Bin Kim, 2024, American Heart Journal.

Cost-Effectiveness of Fractional Flow Reserve–Guided Treatment for Acute Myocardial Infarction and Multivessel Disease

Min Chul Kim, Hyun Kuk Kim, E. Guallar, 2024, JAMA network open.

Very early vs delayed invasive strategy in high-risk NSTEMI patients without hemodynamic instability: Insight from the KAMIR-NIH

Jeong-Rang Park, J. Hwang, Kyehwan Kim, 2024, PloS one.

Predictors and Long-Term Clinical Impact of Heart Failure With Improved Ejection Fraction After Acute Myocardial Infarction.

I. Choi, Sungmin Lim, E. Choo, 2024, Journal of the American Heart Association.

Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction

C. Choi, S. Rha, D. O. Kang, 2024, Texas Heart Institute journal.

Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock

S. Chae, I. Seong, J. Chae, 2024, Scientific reports.

Optimal timing of revascularization for patients with non-ST segment elevation myocardial infarction and severe left ventricular dysfunction

Min Chul Kim, D. Sim, J. Hahn, 2024, Medicine.